Dennis Schade

1.6k total citations
49 papers, 973 citations indexed

About

Dennis Schade is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Dennis Schade has authored 49 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 10 papers in Physiology and 9 papers in Oncology. Recurrent topics in Dennis Schade's work include Nitric Oxide and Endothelin Effects (10 papers), Pluripotent Stem Cells Research (7 papers) and TGF-β signaling in diseases (7 papers). Dennis Schade is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Pluripotent Stem Cells Research (7 papers) and TGF-β signaling in diseases (7 papers). Dennis Schade collaborates with scholars based in Germany, United States and Netherlands. Dennis Schade's co-authors include Bernd Clement, Joscha Kotthaus, Erik Willems, Mark Mercola, Marion Lanier, John R. Cashman, Paul Bushway, Walter Raasch, Helge Müller‐Fielitz and Stefan Heinrichs and has published in prestigious journals such as Chemical Communications, Biochemical Journal and Cell stem cell.

In The Last Decade

Dennis Schade

47 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis Schade Germany 17 568 240 119 107 86 49 973
Sarah A. Head United States 14 465 0.8× 121 0.5× 133 1.1× 98 0.9× 93 1.1× 32 854
Ramesh Ummanni India 25 756 1.3× 494 2.1× 167 1.4× 60 0.6× 77 0.9× 64 1.6k
Weiwei An China 21 694 1.2× 158 0.7× 66 0.6× 78 0.7× 84 1.0× 31 1.2k
Mark W. Kunkel United States 21 748 1.3× 247 1.0× 252 2.1× 59 0.6× 51 0.6× 36 1.3k
Huali Shen China 23 907 1.6× 66 0.3× 149 1.3× 73 0.7× 73 0.8× 61 1.4k
Jingjie Tang China 19 862 1.5× 125 0.5× 92 0.8× 73 0.7× 367 4.3× 31 1.4k
Vadim S. Pokrovsky Russia 21 646 1.1× 119 0.5× 128 1.1× 97 0.9× 33 0.4× 111 1.2k
Ray M. Lee United States 19 868 1.5× 69 0.3× 112 0.9× 91 0.9× 35 0.4× 31 1.1k
Junxian Lim Australia 21 543 1.0× 147 0.6× 138 1.2× 107 1.0× 55 0.6× 42 1.1k

Countries citing papers authored by Dennis Schade

Since Specialization
Citations

This map shows the geographic impact of Dennis Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Schade more than expected).

Fields of papers citing papers by Dennis Schade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Schade. The network helps show where Dennis Schade may publish in the future.

Co-authorship network of co-authors of Dennis Schade

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Schade. A scholar is included among the top collaborators of Dennis Schade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Schade. Dennis Schade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schröder, Lena, Susanne Hille, Anca Remes, et al.. (2025). Directed Evolution of AAV9 for Efficient Gene Expression in Cardiomyocytes In Vitro and In Vivo. Human Gene Therapy. 36(3-4). 101–115. 1 indexed citations
2.
Schulig, Lukas, Georg Manolikakes, Dennis Schade, et al.. (2024). Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors. Cancers. 16(20). 3441–3441. 2 indexed citations
3.
Palm, Gottfried J., et al.. (2024). A Novel C3/C4-Fused Indole Scaffold through Acid-Catalyzed Cascade Reaction. Molecules. 29(13). 3064–3064. 1 indexed citations
4.
Schröder, Lena, Anca Remes, Susanne Hille, et al.. (2024). AAV library screening identifies novel vector for efficient transduction of human aorta. Gene Therapy. 32(2). 154–162. 2 indexed citations
5.
Schade, Dennis, Lauren Drowley, Qing‐Dong Wang, Alleyn T. Plowright, & Boris Greber. (2022). Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human iPS cell-derived cardiomyocytes. Bioorganic & Medicinal Chemistry. 65. 116782–116782. 5 indexed citations
6.
Brand, Silke, Peter Schröder, Jessica Roos, et al.. (2018). Combined Proteomic and In Silico Target Identification Reveal a Role for 5-Lipoxygenase in Developmental Signaling Pathways. Cell chemical biology. 25(9). 1095–1106.e23. 14 indexed citations
7.
Dietrich, L., Kenneth Ewan, Tanja Bange, et al.. (2017). Cell Permeable Stapled Peptide Inhibitor of Wnt Signaling that Targets β-Catenin Protein-Protein Interactions. Cell chemical biology. 24(8). 958–968.e5. 91 indexed citations
8.
Hoffmann, Anja, Dennis Schade, Johannes Kirchmair, et al.. (2016). Platform for determining the inhibition profile of neuraminidase inhibitors in an influenza virus N1 background. Journal of Virological Methods. 237. 192–199. 5 indexed citations
9.
Marquardt, Viktoria, Brigita Vı̄gante, Г. Дубурс, et al.. (2015). Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors. European Journal of Medicinal Chemistry. 95. 249–266. 21 indexed citations
10.
Rao, Jyoti, Martin J. Pfeiffer, Stefan L. Frank, et al.. (2015). Stepwise Clearance of Repressive Roadblocks Drives Cardiac Induction in Human ESCs. Cell stem cell. 18(3). 341–353. 79 indexed citations
11.
Schade, Dennis, Joscha Kotthaus, Helge Müller‐Fielitz, et al.. (2015). Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability. Journal of Pharmaceutical Sciences. 104(9). 3208–3219. 19 indexed citations
12.
Willems, Erik, Dennis Schade, Wenqing Cai, et al.. (2012). Small Molecule-Mediated TGF-β Type II Receptor Degradation Promotes Cardiomyogenesis in Embryonic Stem Cells. Cell stem cell. 11(2). 242–252. 106 indexed citations
13.
Kotthaus, Joscha, et al.. (2011). Synthesis and biological evaluation of l-valine-amidoximeesters as double prodrugs of amidines. Bioorganic & Medicinal Chemistry. 19(6). 1907–1914. 12 indexed citations
14.
Schade, Dennis, et al.. (2011). Prodrug design for the potent cardiovascular agent Nω-hydroxy-l-arginine (NOHA): Synthetic approaches and physicochemical characterization. Organic & Biomolecular Chemistry. 9(14). 5249–5249. 15 indexed citations
15.
Kotthaus, Joscha, et al.. (2011). New Prodrugs of the Antiprotozoal Drug Pentamidine. ChemMedChem. 6(12). 2233–2242. 18 indexed citations
16.
Schade, Dennis, et al.. (2010). Modulating the NO generating system from a medicinal chemistry perspective: Current trends and therapeutic options in cardiovascular disease. Pharmacology & Therapeutics. 126(3). 279–300. 33 indexed citations
17.
Kotthaus, Joscha, Torsten Steinmetzer, Dennis Schade, Andreas van de Locht, & Bernd Clement. (2009). Metabolism and distribution of two highly potent and selective peptidomimetic inhibitors of matriptase. Xenobiotica. 40(2). 93–101. 4 indexed citations
18.
Schade, Dennis, et al.. (2009). Arylazoamidoximes and Related Compounds as NO‐modulators. Archiv der Pharmazie. 343(1). 9–16. 1 indexed citations
19.
Schade, Dennis, et al.. (2009). The Peptidylglycine α‐Amidating Monooxygenase (PAM): A Novel Prodrug Strategy for Amidoximes and N‐Hydroxyguanidines?. ChemMedChem. 4(10). 1595–1599. 10 indexed citations
20.
Schade, Dennis, et al.. (2008). Structure–activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: Alkenyl-amidines as new leads. Bioorganic & Medicinal Chemistry. 16(24). 10205–10209. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah A. Head Breakdown of academic impact, for papers by Ramesh Ummanni Breakdown of academic impact, for papers by Weiwei An Breakdown of academic impact, for papers by Mark W. Kunkel Breakdown of academic impact, for papers by Huali Shen Breakdown of academic impact, for papers by Jingjie Tang Breakdown of academic impact, for papers by Vadim S. Pokrovsky Breakdown of academic impact, for papers by Ray M. Lee Breakdown of academic impact, for papers by Junxian Lim
Rankless by CCL
2026